Baker Brothers Advisors - CLEMENTIA PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$97,208,000
+121.9%
3,724,4450.0%0.62%
+73.3%
Q4 2018$43,799,000
+103.1%
3,724,445
+92.6%
0.36%
+152.8%
Q3 2018$21,560,000
+37.4%
1,933,624
+62.1%
0.14%
+20.3%
Q2 2018$15,695,000
+314.3%
1,192,595
+377.0%
0.12%
+268.8%
Q1 2018$3,788,000
-20.2%
250,0000.0%0.03%
-22.0%
Q4 2017$4,745,000
+12.4%
250,0000.0%0.04%
+20.6%
Q3 2017$4,223,000250,0000.03%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$176,082,0001.68%
NEA Management Company, LLC 2,141,697$36,173,0001.27%
RA Capital Management 585,403$9,887,0000.89%
DAFNA Capital Management LLC 60,000$1,013,0000.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 819,508$13,841,0000.54%
EcoR1 Capital, LLC 194,166$3,279,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 163,000$2,753,0000.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 462,387$7,810,0000.35%
Rock Springs Capital Management LP 345,000$5,827,0000.27%
Perceptive Advisors 704,500$12,582,0000.24%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders